50474-983-86 |
50474-983 |
HUMAN PRESCRIPTION DRUG |
RYSTIGGO |
ROZANOLIXIZUMAB |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20240715 |
N/A |
BLA |
BLA761286 |
UCB, Inc. |
ROZANOLIXIZUMAB |
140 mg/mL |
1 VIAL, GLASS in 1 CARTON (50474-983-86) / 6 mL in 1 VIAL, GLASS |
50474-981-83 |
50474-981 |
HUMAN PRESCRIPTION DRUG |
RYSTIGGO |
ROZANOLIXIZUMAB |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20240715 |
N/A |
BLA |
BLA761286 |
UCB, Inc. |
ROZANOLIXIZUMAB |
140 mg/mL |
1 VIAL, GLASS in 1 CARTON (50474-981-83) / 3 mL in 1 VIAL, GLASS |
50474-980-79 |
50474-980 |
HUMAN PRESCRIPTION DRUG |
RYSTIGGO |
ROZANOLIXIZUMAB |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20230711 |
N/A |
BLA |
BLA761286 |
UCB, Inc. |
ROZANOLIXIZUMAB |
140 mg/mL |
1 VIAL, GLASS in 1 CARTON (50474-980-79) / 2 mL in 1 VIAL, GLASS |
50474-982-84 |
50474-982 |
HUMAN PRESCRIPTION DRUG |
RYSTIGGO |
ROZANOLIXIZUMAB |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20240715 |
N/A |
BLA |
BLA761286 |
UCB, Inc. |
ROZANOLIXIZUMAB |
140 mg/mL |
1 VIAL, GLASS in 1 CARTON (50474-982-84) / 4 mL in 1 VIAL, GLASS |